Skip to main content
NB

NuroKor Bioelectronics

The startup develops bioelectronic ultra-wearable personal medical devices that utilize bioelectrical medicine and neurophysiology to provide non-invasive pain management and body therapy. By harnessing bio currents, these devices offer users a method to improve health and well-being without invasive procedures.

Jacksonville, United StatesFounded 2018101K+ followers
Updated 3 months ago

Funding

$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Chronic pain, sports injuries, and tissue damage often require invasive treatments or pharmaceutical interventions, which can lead to side effects and prolonged recovery times. Existing non-invasive pain management solutions may lack personalization and targeted delivery, limiting their effectiveness for diverse conditions and individual needs.

Solution

NuroKor develops bioelectronic devices that utilize neurostimulation to provide non-invasive pain relief, accelerate recovery, and promote tissue regeneration. These wearable devices deliver targeted electrical signals to modulate nerve activity, reduce inflammation, and stimulate the body's natural healing processes. The technology offers personalized therapy options for a range of conditions, including musculoskeletal pain, sports injuries, diabetic neuropathy, and wound healing. NuroKor's devices aim to reduce reliance on medication and provide a convenient, drug-free alternative for pain management and rehabilitation across consumer, clinical, and animal health applications.

Target Audience

The primary target audience includes individuals seeking non-invasive pain management solutions, athletes recovering from injuries, clinicians looking for drug-free treatment options, and pet owners seeking to improve animal health and recovery.

Features

  • Wearable devices delivering targeted transcutaneous peripheral nerve stimulation (TPNS) and microcurrent stimulation (MCS)
  • Multiple therapy modes to address acute and chronic pain, muscle recovery, and tissue repair
  • App-controlled interface for personalized treatment parameters and progress tracking
  • Wireless connectivity for remote monitoring and data analysis
  • Proprietary waveforms designed to optimize nerve stimulation and cellular response
  • Integration with DNA sequencing for personalized health profiles (KorDNA)
  • Dedicated product lines for consumer, clinical, equine, and canine applications
This profile is AI-generated and may contain inaccuracies.